Chemoradiation for cervical cancer treatment portends high risk of pelvic floor dysfunction.

Goal: To assess the impact of chemoradiation on pelvic floor (PF) muscle function after the treatment of cervical cancer (CC).

Methods: We performed a prospective cohort study of women between the ages of 20 and 70 years old who had a diagnosis of CC. Patients were treated with chemoradiation at the Barretos Cancer Hospital (BCH), between August 2016 and July 2017.